Allergy drug inhibits hepatitis C in mice
NIH study suggests alternative drug to treat virus
2015-04-08
(Press-News.org) An over-the-counter drug indicated to treat allergy symptoms limited hepatitis C virus activity in infected mice, according to a National Institutes of Health study. The results suggest that the drug, chlorcyclizine HCl (CCZ), potentially could be used to treat the virus in people. Results were published April 8 in Science Translational Medicine.
The hepatitis C virus (HCV) causes liver inflammation and often leads to serious complications such as cirrhosis. Early diagnosis and treatment of HCV can prevent liver damage. Drugs are available to treat HCV, but costs can reach tens of thousands of dollars.
"Although hepatitis C is curable, there is an unmet need for effective and affordable medication," said lead author T. Jake Liang, M.D., senior investigator at NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). "CCZ is a promising candidate for part of a treatment regimen for this potentially life-threatening disease."
Conducted at the NIH campus in Bethesda, Maryland, the study found that CCZ blocked the early stage of HCV infection likely by impairing the ability of the virus to enter human liver cells grafted in the mice. The outcome was similar to that of commonly used antiviral drugs but without those drugs' toxic side effects.
"Using an innovative high-throughput screening process, we identified CCZ as a potent inhibitor of hepatitis C," said Anton Simeonov, Ph.D., acting scientific director of NIH's National Center for Advancing Translational Sciences (NCATS), which collaborated in the study. "Identifying already approved drugs from the NCATS Pharmaceutical Collection may offer a faster route to potential discovery of treatments for all diseases."
The researchers will next study how the drug affects people. CCZ is currently used for the treatment of allergies, not for HCV. "People should not take CCZ to treat their hepatitis C until it has been demonstrated that CCZ can be used safely and effectively for that purpose," cautions Liang.
"NIH research is vital to finding creative solutions for some of today's most serious public health issues," said NIDDK Director Griffin P. Rodgers, M.D. "The CCZ medication may eventually provide an affordable alternative to costly options, especially in low-resource communities where hepatitis C infection is widespread."
INFORMATION:
HCV infection affects an estimated 185 million people worldwide. People with hepatitis C interested in participating in clinical research on CCZ may call 1-866-444-2214 (TTY 1-866-411-1010) or visit http://www.clinicaltrials.gov (Clinical Trial # NCT02118012) for information. Support for both studies comes from the intramural research programs of the NIDDK and NCATS and from Hiroshima University.
The NIDDK, a component of the NIH, conducts and supports research on diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition and obesity; and kidney, urologic and hematologic diseases. Spanning the full spectrum of medicine and afflicting people of all ages and ethnic groups, these diseases encompass some of the most common, severe and disabling conditions affecting Americans. For more information about the NIDDK and its programs, see http://www.niddk.nih.gov.
The National Center for Advancing Translational Sciences is a distinctly different entity in the research ecosystem. Rather than targeting a particular disease or fundamental science, NCATS focuses on what is common across diseases and the translational process. The Center emphasizes innovation and deliverables, relying on the power of data and new technologies to develop, demonstrate and disseminate advancements in translational science that bring about tangible improvements in human health. For more information, visit http://www.ncats.nih.gov.
The National Institutes of health, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
NIH...Turning Discovery Into Health®
ELSE PRESS RELEASES FROM THIS DATE:
2015-04-08
Male offspring appear to benefit more than females from the positive effects of exercise during pregnancy, an animal study by UNSW medical researchers has found.
The study in rats also found mothers who exercised moderately while pregnant reduced their offspring's body weight, insulin and blood glucose levels, potentially lessening their risk of developing metabolic disorders such type-2 diabetes later in life.
The findings were published today in the journal PLOS ONE.
The UNSW team led by Professor Margaret Morris, Head of Pharmacology from the School of Medical ...
2015-04-08
Given the alarming rise of antibiotic-resistant bacteria, and the long lead-in time for developing novel drugs, the discovery of new ways to use the antibiotics already available and approved for use in humans is paramount. It is generally believed that to eliminate a bacterial infection before the onset of drug resistance one must treat with large doses of antibiotics, but recent research has indicated that this type of treatment might actually be driving the emergence of drug-resistant pathogens.
New research publishing April 8th in the Open Access journal PLOS Biology ...
2015-04-08
Pioneering new research has unlocked a new technique to help combat the rise of antibiotic-resistant bacteria, that cause debilitating and often life-threatening human illness.
Researchers from the University of Exeter has shown that the use of 'sequential treatments' - using alternating doses of antibiotics - might offer effective treatment against bacterial infection.
Crucially, the research also demonstrates this technique for administering treatment also reduces the risk of the bacteria becoming resistant to antibiotics, and so maintaining the long-term effectiveness ...
2015-04-08
EVANSTON, Ill. --- A new approach to analyzing baseball-pitching biomechanics may one day give players more personalized feedback and help prevent elbow injuries.
In a computer simulation study of baseball pitching, Northwestern University biomedical engineers found that the strength of the elbow muscles of a baseball pitcher likely play a bigger role in injury risk and prevention than previously thought.
The motion analysis approach currently used in the baseball industry to provide athletes with injury-risk feedback is not sophisticated enough to estimate what an ...
2015-04-08
WELLESLEY, Mass. - A new study by Heather Mattila, a leading honey bee ecologist and Assistant Professor of Biological Sciences at Wellesley College, published on April 8 in PLOS ONE, reveals that inadequate access to pollen during larval development has lifelong consequences for honey bees, leading not only to smaller workers and shorter lifespans, but also to impaired performance and productivity later in life. For the first time, this study demonstrates a crucial link between poor nutrition at a young age, and foraging and waggle dancing, the two most important activities ...
2015-04-08
In early childhood, the neurons inside children's developing brains form connections between various regions of brain "real estate." As described in a paper published last week in the journal Biological Psychiatry, cognitive neuroscientists at San Diego State University found that in children and adolescents with autism spectrum disorder, the connections between the cerebral cortex and the cerebellum appear to be overdeveloped in sensorimotor regions of the brain. This overdevelopment appears to muscle in on brain "real estate" that in typically developing children is more ...
2015-04-08
A single infusion of an experimental anti-HIV antibody called 3BNC117 resulted in significantly decreased HIV levels that persisted for as long as 28 days in HIV-infected individuals, according to Phase 1 clinical trial findings published online today in Nature. Major funding for the research was provided by the Bill and Melinda Gates Foundation, The Rockefeller University, and supported in part by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the NIH. The research was led by long-time NIAID grantee Michel C. Nussenzweig, M.D., Ph.D., ...
2015-04-08
The four collaborating organizations are the American College of Nurse-Midwives; the American College of Obstetricians and Gynecologists; the Association of Women's Health, Obstetric and Neonatal Nurses; and the Society for Maternal-Fetal Medicine. Additionally, these organizations partnered with VitalSmarts, a research and training organization.
The report, "Transforming Communication and Safety Culture in Intrapartum Care: A Multi-organization Blueprint," follows previous research on safety concerns during childbirth and communication among labor and delivery teams. ...
2015-04-08
Washington, DC--Pesticide exposure, not obesity alone, can contribute to increased cardiovascular disease risk and inflammation in premenopausal women, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
The study looked at the effects of exposure to polychlorinated pesticides such as DDT. Although DDT was banned in many countries in the 1970s, it remains widespread in the environment and food supply.
DDT was one of the first recognized endocrine-disrupting chemicals, according to the introductory guide to endocrine-disrupting ...
2015-04-08
A collaboration led by Shigeyuki Yokoyama of RIKEN and Takashi Kadowaki and Toshimasa Yamauchi of the University of Tokyo has used the SPring-8 synchrotron facility in Harima, Japan to elucidate the structure of two receptors of adiponectin, a protein that is associated with obesity and diabetes. The researchers hope that in the future this work, which was published in Nature today, will pave the way toward designing drugs that target these two receptors, AdipoR1 and AdipoR2, to reduce the early mortality associated with diabetes.
Adiponectin, a hormone secreted by fat ...
LAST 30 PRESS RELEASES:
[Press-News.org] Allergy drug inhibits hepatitis C in mice
NIH study suggests alternative drug to treat virus
